Managing the jaundiced newborn: A persistent challenge

CMAJ

Volumn 187, Issue 5, 2015, Pages 335-343

  Maisels, M Jeffrey ^a  

^a Beaumont Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

BRAIN DAMAGE; BREAST FEEDING; CLINICAL ASSESSMENT; DISEASE SEVERITY; EXCHANGE BLOOD TRANSFUSION; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; NEWBORN; NEWBORN JAUNDICE; PATIENT CARE; PATIENT IDENTIFICATION; PHOTOTHERAPY; PRACTICE GUIDELINE; PREDICTION; REVIEW; RISK BENEFIT ANALYSIS; COMPLICATION; DEVELOPED COUNTRY; JAUNDICE, NEONATAL; RISK ASSESSMENT; RISK FACTOR;

BREAST FEEDING; DEVELOPED COUNTRIES; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84924911621     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.122117     Document Type: Article

References (51)

1. Sgro M, Campbell DM, Kandasamy S, et al. Incidence of chronic bilirubin encephalopathy in Canada, 2007-2008. Pediatrics 2012;130:e886-90.
2. Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ 2010;340:C2409.
3. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
4. Canadian Paediatric Society. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - summary. Paediatr Child Health 2007;12:401-18.
5. Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirubinemia in the newborn infant > 35 weeks' gestation: an update with clarifications. Pediatrics 2009;124:1193-8.
6. Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012.
7. Keren R, Luan X, Friedman S, et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008;121:e170-9.
8. Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr 2013;162:477-82.e1.
9. Maisels MJ, Pathak A, Nelson NM, et al. Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants. J Clin Invest 1971;50:1-8.
10. Kaplan M, Muraca M, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics 2002;110:e47.
11. Newman TB, Escobar GJ, Gonzales VM, et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 1999;104:1198-203.
12. Maisels MJ, Newman TB. The epidemiology of neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012:97-113.
13. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;108:31-9.
14. Shapiro SM. Kernicterus. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012:229-42.
15. Brites D, Brito MA. Bilirubin toxicity. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012:115-43.
16. Maisels MJ, Newman TB. Prevention, screening, and postnatal management of neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012:175-94.
17. Johnson L, Bhutani VK, Karp K, et al. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009;29:S25-45.
18. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Pediatrics 1999;103:6-14.
19. Maisels MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics 1999;103:493-5.
20. Chinevere TD, Murray CK, Grant E, et al. Prevalence of glucose-6-phosphate dehydrogenase deficiency in US army personnel. Mil Med 2006;171:905-7.
21. Maisels MJ, Clune S, Coleman K, et al. The natural history of jaundice in predominantly breast-fed infants. Pediatrics 2014;134:e340-5.
22. Keren R, Tremont K, Luan X, et al. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F317-22.
23. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 1969;118:454-8.
24. Purcell N, Beeby PJ. The influence of skin temperature and skin perfusion on the cephalocaudal progression of jaundice in newborns. J Paediatr Child Health 2009;45:582-6.
25. Bhutani VK, Gourley GR, Adler S, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:E17.
26. Maisels MJ, Engle W, Wainer S, et al. Transcutaneous bilirubin levels in an outpatient and office population. J Perinatol 2011;31:621-4.
27. Maisels MJ. Noninvasive measurements of bilirubin. Pediatrics 2012;129:779-81.
28. Wainer S, Parmar SM, Allegro D, et al. Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia. Pediatrics 2012;129:77-86.
29. Maisels MJ, Kring E. Trancutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics 1997;99:599-601.
30. Maisels MJ. Neonatal transcutaneous bilirubin measurements: an opportunity to enhance laboratory utilization and improve patient care. Clin Chem 2012;58:1395-6.
31. Maisels MJ, DeRidder JM, Kring EA, et al. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 2009;29:612-7.
32. Engle WD, Jackson GL, Stehel EK, et al. Evaluation of a transcutaneous jaundice meter following hospital discharge in term and near-term neonates. J Perinatol 2005;25:486-90.
33. Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr 2002;91:203-11.
34. Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 or more weeks' of gestation. Pediatrics 2006;117:1169-73.
35. Kuzniewicz MW, Escobar GJ, Newman TB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics 2009;124:1031-9.
36. Watchko JF, Kaplan M, Stark AR, et al. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol 2013;33:499-504.
37. Kaplan M, Hammerman C. Hemolytic disorders and their management. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012:145-73.
38. Sgro M, Campbell DM, Fallah S, et al. Kernicterus (final report). In: Canadian Paediatric Surveillance Program 2009 results. Ottawa: Canadian Paediatric Society and Public Health Agency of Canada; 2009:30-2. Available: www.cpsp.cps.ca/uploads/publications/Results-2009.pdf (accessed 2014 Sept. 11).
39. Gärtner U, Goeser T, Wolkoff AW. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 1997;113:1707-13.
40. Breastfeeding in the hospital, the postpartum period. In: Breastfeeding handbook for physicians. Washington (DC): American Academy of Pediatrics, American College of Obstetricians and Gynecologists; 2006:81-99.
41. Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr 1980;96:521-7.
42. Cashore WJ, Oh W, Brodersen R. Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand 1983;72:415-9.
43. Wennberg RP, Ahlfors CE, Bhutani V, et al. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006;117:474-85.
44. Bratlid D. How bilirubin gets into the brain. Clin Perinatol 1990;17:449-65.
45. Maisels MJ. Phototherapy - traditional and nontraditional. J Perinatol 2001;21:S93-7.
46. Newman TB, Kuzniewicz MW, Liljestrand P, et al. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics 2009;123:1352-9.
47. Gourley GR, Li Z, Kreamer BL, et al. A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics 2005;116:385-91.
48. Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. Pediatrics 1993;91:470-3.
49. Maisels MJ, Newman TB. Phototherapy and other treatments. In: Stevenson DK, Maisels MJ, Watchko JF, editors. Care of the jaundiced neonate. New York: McGraw Hill; 2012:195-227.
50. Csoma Z, Toth-Molnar E, Balogh K, et al. Neonatal blue light phototherapy and melanocytic nevi: a twin study. Pediatrics 2011;128:e856-64.
51. Amato M, Howald H, von Muralt G. Interruption of breastfeeding vs. phototherapy as treatment of hyperbilirubinemia in full term infants. Helv Paediatr Acta 1985;40:127-31.